US Stock MarketDetailed Quotes

Edgewise Therapeutics (EWTX)

Watchlist
  • 38.010
  • +6.560+20.86%
Close May 5 16:00 ET
4.09BMarket Cap-23.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Edgewise Therapeutics (EWTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-31.91%-143.82M
-43.16%-38.59M
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-18.58%-109.03M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.1M
-25.29%-28.6M
Net income from continuing operations
-25.40%-167.8M
-26.61%-50.22M
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
Depreciation and amortization
-1.05%2.27M
-8.59%575K
-5.32%570K
6.18%567K
5.52%554K
32.22%2.29M
18.01%629K
21.13%602K
15.84%534K
117.84%525K
Change In working capital
-152.03%-5.37M
-61.72%2.66M
-128.21%-709K
-180.30%-2.56M
-105.17%-4.76M
762.05%10.33M
3,553.23%6.94M
158.01%2.51M
1,033.63%3.19M
-16.47%-2.32M
-Change in prepaid assets
-341.89%-7.96M
-271.08%-2.72M
-264.10%-1.3M
-353.02%-2.47M
-2,246.03%-1.48M
192.65%3.29M
518.73%1.59M
168.37%791K
158.93%977K
82.45%-63K
-Change in payables and accrued expense
-54.01%3.34M
9.98%5.57M
-59.07%778K
-96.02%95K
-48.23%-3.1M
246.02%7.26M
1,615.25%5.06M
-14.91%1.9M
81.38%2.39M
-19.68%-2.09M
-Change in other current liabilities
-240.00%-748K
-165.65%-193K
-5.59%-189K
-9.36%-187K
-9.15%-179K
-111.54%-220K
351.28%294K
-73.79%-179K
---171K
-241.38%-164K
Cash from discontinued investing activities
Operating cash flow
-31.91%-143.82M
-43.16%-38.59M
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-18.58%-109.03M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.1M
-25.29%-28.6M
Investing cash flow
Cash flow from continuing investing activities
82.24%-32.79M
137.85%49.76M
40.82%35.72M
-533.97%-162.17M
116.36%43.9M
-279.48%-184.66M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
Net PPE purchase and sale
80.49%-256K
73.36%-73K
82.88%-89K
77.38%-50K
85.19%-44K
77.16%-1.31M
-70.19%-274K
-13.79%-520K
70.88%-221K
93.20%-297K
Net investment purchase and sale
82.26%-32.53M
135.12%49.84M
38.34%35.81M
-531.29%-162.12M
116.40%43.94M
-268.78%-183.34M
-21.91%21.2M
8.40%25.88M
794.76%37.59M
-601.80%-268.01M
Cash from discontinued investing activities
Investing cash flow
82.24%-32.79M
137.85%49.76M
40.82%35.72M
-533.97%-162.17M
116.36%43.9M
-279.48%-184.66M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
Financing cash flow
Cash flow from continuing financing activities
-21.33%196.09M
37.31%3.98M
-50.23%1.66M
9,542.98%188.23M
-99.08%2.22M
368.82%249.25M
-94.54%2.9M
1,679.62%3.33M
429.00%1.95M
1,147,866.67%241.07M
Net common stock issuance
-21.65%187.36M
--0
--0
--187.36M
--0
354.50%239.15M
--0
--0
--0
--239.15M
Proceeds from stock option exercised by employees
-15.84%8.73M
37.31%3.98M
-53.23%1.66M
-58.45%831K
17.39%2.26M
1,354.14%10.37M
804.69%2.9M
118,133.33%3.55M
442.01%2M
9,071.43%1.93M
Net other financing activities
----
----
----
----
---38K
-58.79%-262K
--0
---214K
----
----
Cash from discontinued financing activities
Financing cash flow
-21.33%196.09M
37.31%3.98M
-50.23%1.66M
9,542.98%188.23M
-99.08%2.22M
368.82%249.25M
-94.54%2.9M
1,679.62%3.33M
429.00%1.95M
1,147,866.67%241.07M
Net cash flow
Beginning cash position
-51.61%41.67M
2.67%46M
-0.19%43.4M
64.95%49.92M
-51.61%41.67M
291.47%86.1M
35.95%44.81M
36.72%43.49M
-37.25%30.26M
291.47%86.1M
Current changes in cash
143.85%19.48M
582.32%15.15M
96.74%2.6M
-149.29%-6.52M
114.79%8.26M
-169.31%-44.43M
-105.91%-3.14M
14.87%1.32M
180.50%13.22M
-312.80%-55.83M
End cash Position
46.76%61.15M
46.76%61.15M
2.67%46M
-0.19%43.4M
64.95%49.92M
-51.61%41.67M
-51.61%41.67M
35.95%44.81M
36.72%43.49M
-37.25%30.26M
Free cash flow
-30.57%-144.07M
-41.99%-38.67M
-24.99%-34.87M
-23.98%-32.63M
-31.20%-37.91M
-12.95%-110.34M
-0.89%-27.23M
-23.89%-27.89M
-25.38%-26.32M
-6.26%-28.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -31.91%-143.82M-43.16%-38.59M-27.04%-34.78M-24.84%-32.58M-32.41%-37.87M-18.58%-109.03M-0.47%-26.96M-24.10%-27.37M-28.99%-26.1M-25.29%-28.6M
Net income from continuing operations -25.40%-167.8M-26.61%-50.22M-19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M-24.90%-28.53M
Depreciation and amortization -1.05%2.27M-8.59%575K-5.32%570K6.18%567K5.52%554K32.22%2.29M18.01%629K21.13%602K15.84%534K117.84%525K
Change In working capital -152.03%-5.37M-61.72%2.66M-128.21%-709K-180.30%-2.56M-105.17%-4.76M762.05%10.33M3,553.23%6.94M158.01%2.51M1,033.63%3.19M-16.47%-2.32M
-Change in prepaid assets -341.89%-7.96M-271.08%-2.72M-264.10%-1.3M-353.02%-2.47M-2,246.03%-1.48M192.65%3.29M518.73%1.59M168.37%791K158.93%977K82.45%-63K
-Change in payables and accrued expense -54.01%3.34M9.98%5.57M-59.07%778K-96.02%95K-48.23%-3.1M246.02%7.26M1,615.25%5.06M-14.91%1.9M81.38%2.39M-19.68%-2.09M
-Change in other current liabilities -240.00%-748K-165.65%-193K-5.59%-189K-9.36%-187K-9.15%-179K-111.54%-220K351.28%294K-73.79%-179K---171K-241.38%-164K
Cash from discontinued investing activities
Operating cash flow -31.91%-143.82M-43.16%-38.59M-27.04%-34.78M-24.84%-32.58M-32.41%-37.87M-18.58%-109.03M-0.47%-26.96M-24.10%-27.37M-28.99%-26.1M-25.29%-28.6M
Investing cash flow
Cash flow from continuing investing activities 82.24%-32.79M137.85%49.76M40.82%35.72M-533.97%-162.17M116.36%43.9M-279.48%-184.66M-22.46%20.92M8.30%25.36M985.65%37.37M-647.10%-268.31M
Net PPE purchase and sale 80.49%-256K73.36%-73K82.88%-89K77.38%-50K85.19%-44K77.16%-1.31M-70.19%-274K-13.79%-520K70.88%-221K93.20%-297K
Net investment purchase and sale 82.26%-32.53M135.12%49.84M38.34%35.81M-531.29%-162.12M116.40%43.94M-268.78%-183.34M-21.91%21.2M8.40%25.88M794.76%37.59M-601.80%-268.01M
Cash from discontinued investing activities
Investing cash flow 82.24%-32.79M137.85%49.76M40.82%35.72M-533.97%-162.17M116.36%43.9M-279.48%-184.66M-22.46%20.92M8.30%25.36M985.65%37.37M-647.10%-268.31M
Financing cash flow
Cash flow from continuing financing activities -21.33%196.09M37.31%3.98M-50.23%1.66M9,542.98%188.23M-99.08%2.22M368.82%249.25M-94.54%2.9M1,679.62%3.33M429.00%1.95M1,147,866.67%241.07M
Net common stock issuance -21.65%187.36M--0--0--187.36M--0354.50%239.15M--0--0--0--239.15M
Proceeds from stock option exercised by employees -15.84%8.73M37.31%3.98M-53.23%1.66M-58.45%831K17.39%2.26M1,354.14%10.37M804.69%2.9M118,133.33%3.55M442.01%2M9,071.43%1.93M
Net other financing activities -------------------38K-58.79%-262K--0---214K--------
Cash from discontinued financing activities
Financing cash flow -21.33%196.09M37.31%3.98M-50.23%1.66M9,542.98%188.23M-99.08%2.22M368.82%249.25M-94.54%2.9M1,679.62%3.33M429.00%1.95M1,147,866.67%241.07M
Net cash flow
Beginning cash position -51.61%41.67M2.67%46M-0.19%43.4M64.95%49.92M-51.61%41.67M291.47%86.1M35.95%44.81M36.72%43.49M-37.25%30.26M291.47%86.1M
Current changes in cash 143.85%19.48M582.32%15.15M96.74%2.6M-149.29%-6.52M114.79%8.26M-169.31%-44.43M-105.91%-3.14M14.87%1.32M180.50%13.22M-312.80%-55.83M
End cash Position 46.76%61.15M46.76%61.15M2.67%46M-0.19%43.4M64.95%49.92M-51.61%41.67M-51.61%41.67M35.95%44.81M36.72%43.49M-37.25%30.26M
Free cash flow -30.57%-144.07M-41.99%-38.67M-24.99%-34.87M-23.98%-32.63M-31.20%-37.91M-12.95%-110.34M-0.89%-27.23M-23.89%-27.89M-25.38%-26.32M-6.26%-28.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.56%
Sample Name
Sample Code
 +14.20%
Sample Name
Sample Code
 +14.18%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+10.58%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.71%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +21.01%
Sample Name
Sample Code
 +20.15%
Sample Name
Sample Code
 +14.82%
4
ASE Technology
ASX
+11.17%
5
Luckin Coffee
LKNCY
+10.14%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report from AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has b Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -